Cargando…
The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer – A New Analysis
Background: The International Bladder Cancer Group (IBCG) recently proposed a new definition of disease progression in non-muscle invasive bladder cancer (NMIBC), including change in T-stage, change to T2 or higher or change from low to high grade. Objective: To establish whether blue light cystosco...
Autores principales: | Kamat, Ashish M., Cookson, Michael, Witjes, J. Alfred, Stenzl, Arnulf, Grossman, H. Barton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927917/ https://www.ncbi.nlm.nih.gov/pubmed/27376146 http://dx.doi.org/10.3233/BLC-160048 |
Ejemplares similares
-
Hexaminolevulinate Blue-Light Cystoscopy in a Patient with Metastatic Melanoma of the Bladder
por: Shukla, Anant, et al.
Publicado: (2016) -
Efficacy and Safety of Hexaminolevulinate Fluorescence Cystoscopy in the Diagnosis of Bladder Cancer
por: Lee, Jae Seung, et al.
Publicado: (2012) -
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018
por: Lotan, Yair, et al.
Publicado: (2019) -
Effects of Supplemental Drugs on Hexaminolevulinate (HAL)-Induced PpIX Fluorescence in Bladder Cancer Cell Suspensions
por: Chan, Kit Man, et al.
Publicado: (2022) -
Early detection of urothelial premalignant lesions using hexaminolevulinate fluorescence cystoscopy in high risk patients
por: Blanco, Salvatore, et al.
Publicado: (2010)